Announced Sat, 4 Jul · 18:03 IST
Sarda Proteins board approves capital hike, MD change, new CFO
Corporate Actions View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Board approved raising authorised equity share capital from Rs 13 crore to Rs 100 crore (from 1.3 crore to 10 crore shares of Rs 10 each). Chirag Thumar resigned as Managing Director; Shirish Savaliya appointed new MD for 5 years. Yagnik Satasiya moved from CFO to Non-Executive Chairperson. Drashti Delvadiya appointed new CFO. Three directors resigned. EGM notice approved, committees reconstituted.
Likely market impact
Major leadership overhaul and a near 8x jump in authorised capital signal expansion plans. Capital hike and director changes need shareholder approval at the EGM.